Takeda Pharmaceutical has received FDA approval for three new treatments for type 2 diabetes - NESINA (alogliptin) and t…
Nesina
FDA Requests More Data on Takeda’s Alogliptin
The FDA has issued a complete response letter to Japanese drug-maker Takeda Pharmaceutical regarding New Drug Applicatio…
Takeda Launches New Type 2 Diabetes Combination Drug
Takeda Pharmaceutical announced the launch of LIOVEL®, a fixed dose combination tablet of NESINA® (alogliptin) and ACTO…
Takeda Resubmits New Type 2 Diabetes Drugs for FDA Approval
Takeda has resubmitted two New Drug Applications (NDA) to the U.S. Food and Drug Administration (FDA) for alogliptin and…
